Skip to main content
Figure 3 | Journal of Translational Medicine

Figure 3

From: Validation of a HLA-A2 tetramer flow cytometric method, IFNgamma real time RT-PCR, and IFNgamma ELISPOT for detection of immunologic response to gp100 and MelanA/MART-1 in melanoma patients

Figure 3

Tetramer assay linearity of dilution. (A) TIL1520 binding to gp100 tetramer. Correlation of % TIL1520 used (x-axis) vs. % gp100 tetramer positive cells detected (y-axis) is shown. (B) TIL1143 binding to MART-1 tetramer. Correlation between % TIL1143 used (x-axis) vs. % MART-1 tetramer positive cells (y-axis) is illustrated.

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us